1 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For May 05, 2025
2 J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer May 03, 2025
4 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Apr 17, 2025
5 Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche! Apr 10, 2025
6 K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! Apr 08, 2025
Read More Apparatus New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression May 01, 2025
Read More Apparatus J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer May 03, 2025
Read More Apparatus Biyze For The Treatment Of Chronic Lymphocytic Leukaemia And Marginal Zone Lymphoma May 07, 2025
Read More Apparatus Angry FDA & CDC: $5 Billion Bivalent Moderna New Crown Vaccine Not As Effective As Monovalent May 16, 2025
Read More Apparatus Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For May 05, 2025
Read More Disease What You Need To Do If Pancreatic Cancer Spreads To Your Liver After Surgery May 12, 2025
